Select Region or Location
Americas
  • Argentina
  • Brazil
  • Canada
  • Mexico
  • United States
  • Other Americas
Europe
  • Austria
  • Belgium
  • Bulgaria
  • Croatia/Hrvatska
  • Cyprus
  • Czech Republic
  • Denmark
  • Estonia
  • Finland
  • France
  • Germany
  • Greece
  • Hungary
  • Ireland
  • Italy
  • Latvia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Malta
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Romania
  • Slovak Republic
  • Slovenia
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • United Kingdom
  • Other Europe
Asia Pacific
  • Australia
  • China
  • India
  • Indonesia
  • Japan
  • Korea, Republic of
  • Malaysia
  • New Zealand
  • Philippines
  • Singapore
  • Thailand
  • Vietnam
  • Other Asia Pacific
Africa And Middle East
  • Egypt
  • Israel
  • Other Africa And Middle East
USD
Home Cart Sign in  
Chemical Structure| 1320288-17-2 Chemical Structure| 1320288-17-2

Structure of UNC0646
CAS No.: 1320288-17-2

Chemical Structure| 1320288-17-2

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

UNC0646 is a potent and selective G9a inhibitor with IC50 of 6 nM.

4.5 *For Research Use Only! Not for Human Use. We Do Not Sell to Patients.

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

DE Stock

US Stock

Asia Stock

Global Stock

In Stock
{[ item.pr_size ]}{[ size_append_text(item.pr_size, proInfo.prAm, 'list') ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

  • {[ item.pr_size ]}
    {[ size_append_text(item.pr_size, proInfo.prAm, 'list') ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of UNC0646

CAS No. :1320288-17-2
Formula : C36H59N7O2
M.W : 621.90
SMILES Code : COC1=CC2=C(NC3CCN(C4CCCCC4)CC3)N=C(N5CCN(C(C)C)CCC5)N=C2C=C1OCCCN6CCCCC6
English Name :N-(1-Cyclohexylpiperidin-4-yl)-2-(4-isopropyl-1,4-diazepan-1-yl)-6-methoxy-7-(3-(piperidin-1-yl)propoxy)quinazolin-4-amine
MDL No. :MFCD22378486
InChI Key :OUKWLRHRXOPODD-UHFFFAOYSA-N
Pubchem ID :53315882

Safety of UNC0646

Related Pathways of UNC0646

epigenetics

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
CAOV3 5 µM 24 hours To evaluate the apoptosis-inducing effect of UNC0646 on CAOV3 cells, results showed that UNC0646 significantly increased the apoptosis rate of CAOV3 cells. Br J Cancer. 2023 Jul;129(1):163-174
Human CD4+ T cells 500 nM 3 to 11 days In the presence of TGF-β and IL-2, UNC0646 combined with sodium butyrate and vitamin C promoted the generation of Foxp3+ iTregs and led to complete demethylation of the CNS2 region of the Foxp3 gene. Am J Transplant. 2020 Sep;20(9):2366-2379
Mouse CD4+ T cells 500 nM 3 to 5 days In the presence of TGF-β and IL-2, UNC0646 combined with sodium butyrate and vitamin C promoted the generation of Foxp3+ iTregs and led to complete demethylation of the CNS2 region of the Foxp3 gene. Am J Transplant. 2020 Sep;20(9):2366-2379
IMR90 0.010 µM (IC50) 48 hours Evaluate the cellular potency of UNC0646 in reducing H3K9me2 levels J Med Chem. 2011 Sep 8;54(17):6139-50.
HCT116 p53 −/− 0.086 µM (IC50) 48 hours Evaluate the cellular potency of UNC0646 in reducing H3K9me2 levels J Med Chem. 2011 Sep 8;54(17):6139-50.
HCT116 wt 0.068 µM (IC50) 48 hours Evaluate the cellular potency of UNC0646 in reducing H3K9me2 levels J Med Chem. 2011 Sep 8;54(17):6139-50.
22RV1 0.014 µM (IC50) 48 hours Evaluate the cellular potency of UNC0646 in reducing H3K9me2 levels J Med Chem. 2011 Sep 8;54(17):6139-50.
PC3 0.012 µM (IC50) 48 hours Evaluate the cellular potency of UNC0646 in reducing H3K9me2 levels J Med Chem. 2011 Sep 8;54(17):6139-50.
MCF7 0.010 µM (IC50) 48 hours Evaluate the cellular potency of UNC0646 in reducing H3K9me2 levels J Med Chem. 2011 Sep 8;54(17):6139-50.
MDA-MB-231 0.026 µM (IC50) 48 hours Evaluate the cellular potency of UNC0646 in reducing H3K9me2 levels J Med Chem. 2011 Sep 8;54(17):6139-50.
A549 cells 2 µM 48 hours Inhibition of G9a methyltransferase activity, reducing H3K9 dimethylation levels Proc Natl Acad Sci U S A. 2012 Nov 27;109(48):19673-8
OVCAR-3 1.5 µM 72 hours To evaluate the anti-tumor activity of UNC0646 on OVCAR-3 cells, results showed IC50 values in the range of 1-3μM, indicating significant anti-tumor effects of UNC0646 on OVCAR-3 cells. Br J Cancer. 2023 Jul;129(1):163-174
SKOV3 1.5 µM 72 hours To evaluate the anti-tumor activity of UNC0646 on SKOV3 cells, results showed IC50 values in the range of 1-3μM, indicating significant anti-tumor effects of UNC0646 on SKOV3 cells. Br J Cancer. 2023 Jul;129(1):163-174

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.61mL

0.32mL

0.16mL

8.04mL

1.61mL

0.80mL

16.08mL

3.22mL

1.61mL

References

 

Historical Records

Categories